Strength

1.6; 3.13; 17.5 g/mL; g/mL; g/mL

NDC

52268001201

Classification

Brand

Dosage Form

SOLUTION, CONCENTRATE

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA022372

On Market Since

8/5/2010

Pharmacological Classes

Calculi Dissolution Agent
Increased Large Intestinal Motility
Increased Large Intestinal Motility
Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Small Intestine Fluid/Electrolyte Absorption
Magnesium Ion Exchange Activity
Osmotic Activity
Osmotic Activity
Osmotic Activity
Osmotic Laxative
Osmotic Laxative
Osmotic Laxative
Potassium Compounds
Potassium Salt
Stimulation Large Intestine Fluid/Electrolyte Secretion

Price History

1W

0.0%

1M

-0.2%

3M

-0.1%

6M

-0.0%

1Y

+0.2%

3Y

+6.4%

5Y

+13.0%

All

+65.8%